AU2011233753A1 - Method to detect tissue degradation leading to inflammation - Google Patents

Method to detect tissue degradation leading to inflammation Download PDF

Info

Publication number
AU2011233753A1
AU2011233753A1 AU2011233753A AU2011233753A AU2011233753A1 AU 2011233753 A1 AU2011233753 A1 AU 2011233753A1 AU 2011233753 A AU2011233753 A AU 2011233753A AU 2011233753 A AU2011233753 A AU 2011233753A AU 2011233753 A1 AU2011233753 A1 AU 2011233753A1
Authority
AU
Australia
Prior art keywords
comp
sample
complement
complex
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011233753A
Other languages
English (en)
Inventor
Anna Blom
Kaisa Happonen
Dick Heinegard
Tore Saxne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anamar AB
Original Assignee
Anamar AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anamar AB filed Critical Anamar AB
Publication of AU2011233753A1 publication Critical patent/AU2011233753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2011233753A 2010-03-31 2011-03-30 Method to detect tissue degradation leading to inflammation Abandoned AU2011233753A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1050310 2010-03-31
SE1050310-0 2010-03-31
PCT/SE2011/050369 WO2011123044A1 (en) 2010-03-31 2011-03-30 Method to detect tissue degradation leading to inflammation

Publications (1)

Publication Number Publication Date
AU2011233753A1 true AU2011233753A1 (en) 2012-09-13

Family

ID=44712493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011233753A Abandoned AU2011233753A1 (en) 2010-03-31 2011-03-30 Method to detect tissue degradation leading to inflammation

Country Status (5)

Country Link
US (1) US20130084584A1 (enExample)
EP (1) EP2553465A4 (enExample)
JP (1) JP2013524213A (enExample)
AU (1) AU2011233753A1 (enExample)
WO (1) WO2011123044A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4642284A (en) * 1983-06-13 1987-02-10 Scripps Clinic And Research Foundation Method and system for detection of complement pathway activation
SE452065B (sv) * 1986-04-11 1987-11-09 Ulf R Nilsson Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
IL84160A0 (en) * 1986-10-16 1988-03-31 Vasocor Method and kit for immune complex assay
EP0888551A1 (en) * 1996-03-19 1999-01-07 Akzo Nobel N.V. Method for predicting the outcome of hepatitis b infection
SE9904236D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
WO2004043237A2 (en) * 2002-11-08 2004-05-27 Barnes-Jewish Hospital Uncoupled collagen synthesis and degradation assays
EP1766411B1 (en) * 2004-05-24 2011-02-23 AnaMar AB Method for determining a tissue degradation process by detection of comp neoepitopes
AU2008262048B2 (en) * 2007-06-07 2013-09-26 Genentech, Inc. C3b antibodies and methods for the prevention and treatment of complement- associated disorders
BRPI0813262A2 (pt) * 2007-06-20 2015-04-14 Schering Corp Biomarcadores de destruição de articulação para terapia de doença inflamatória de articulação anti-il-17a
EP2307451B1 (en) * 2008-03-21 2016-05-25 Universiteit Hasselt Biomarkers for rheumatoid arthritis

Also Published As

Publication number Publication date
JP2013524213A (ja) 2013-06-17
WO2011123044A1 (en) 2011-10-06
US20130084584A1 (en) 2013-04-04
EP2553465A1 (en) 2013-02-06
EP2553465A4 (en) 2013-10-23

Similar Documents

Publication Publication Date Title
JP7441662B2 (ja) ｐＫａｌ関連疾病の評価、アッセイおよび治療
Rau et al. Laboratory markers of severe acute pancreatitis
Dambinova et al. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke
KR101678703B1 (ko) 갈렉틴-３ 면역검정
TR201815856T4 (tr) Bradikinin-aracılı rahatsızlıkların değerlendirilmesi ve tedavisi.
JP3517652B2 (ja) 中枢神経系の損傷を検出するためのアッセイ
CN104024858A (zh) 预测心血管风险的诊断试验
JP7265325B2 (ja) 好塩基球の活性化を検出するための方法
WO2020141608A1 (ja) 潰瘍性大腸炎及び原発性硬化性胆管炎の検査方法
US20230258660A1 (en) A method for distinguishing healthy individuals from individuals having infectious or inflammatory conditions
JP7168688B2 (ja) 補体Ｃ４ｄアッセイ
US20130084584A1 (en) Method to detect tissue degradation leading to inflammation
CN114341643B (zh) 用于测量血浆样品中功能性c1-酯酶抑制剂(c1-inh)的侧向流免疫测定
JPWO2012067151A1 (ja) ＣａｒｔｉｌａｇｅＡｃｉｄｉｃＰｒｏｔｅｉｎ１蛋白質による脳梗塞の検査方法
CN107484423A (zh) 通过测量抗ccp和抗pik3cd来评估类风湿性关节炎的方法
US20040241763A1 (en) Method for diagnosing multiple sclerosis
JP2011237402A (ja) ガレクチン−３結合蛋白質による脳梗塞の検査方法
Badawy et al. Leptospirosis among Febrile Patients in the Intensive Care Unit
EP3327441B1 (en) Method for assisting diagnosis of conditions of myelofibrosis, method for monitoring therapeutic effect, and a device therefor
JP5989893B2 (ja) インテグリンβサブユニットの静脈血栓塞栓の診断における使用
JP2023525219A (ja) タンパク質－アルギニンデイミナーゼ１（ｐａｄ１）自己抗原を使用する関節リウマチの診断及び評価のための組成物及び方法
JP2020046412A (ja) ＩｇＧ４関連疾患の検査方法
EP3056903A1 (en) Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-Casp8
EP3056904A1 (en) Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-MCM3

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application